Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
19.95
+0.06 (0.30%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Acadia Pharmaceuticals Employees
As of December 31, 2025, Acadia Pharmaceuticals had 798 total employees, including 796 full-time and 2 part-time employees. The number of employees increased by 144 or 22.02% compared to the previous year.
Employees
798
Change (1Y)
144
Growth (1Y)
22.02%
Revenue / Employee
$1,426,872
Profits / Employee
$476,797
Market Cap
3.44B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| Denali Therapeutics | 507 |
| Xenon Pharmaceuticals | 370 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Celcuity | 155 |
| IDEAYA Biosciences | 145 |
ACAD News
- 5 days ago - Acadia Pharmaceuticals announces USPTO allowance of patent covering Trofinetide - TheFly
- 5 days ago - Acadia Pharmaceuticals Announces Allowance of U.S. Patent Covering Weight-Banded Dosing of Trofinetide, extending U.S. patent protections to March 2041 - Business Wire
- 9 days ago - Acadia price target lowered to $33 from $37 at H.C. Wainwright - TheFly
- 9 days ago - Acadia Pharmaceuticals price target lowered to $35 from $41 at Needham - TheFly
- 9 days ago - Acadia Pharmaceuticals price target lowered to $31 from $38 at Deutsche Bank - TheFly
- 9 days ago - Acadia Pharmaceuticals price target lowered to $34 from $36 at BMO Capital - TheFly
- 9 days ago - Acadia Pharmaceuticals price target lowered to $33 from $36 at Citizens - TheFly
- 10 days ago - Acadia Pharmaceuticals price target lowered to $33 from $40 at Citi - TheFly